Lee Lee Chan

451 total citations
22 papers, 340 citations indexed

About

Lee Lee Chan is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lee Lee Chan has authored 22 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Genetics and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lee Lee Chan's work include Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (9 papers) and Erythropoietin and Anemia Treatment (4 papers). Lee Lee Chan is often cited by papers focused on Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (9 papers) and Erythropoietin and Anemia Treatment (4 papers). Lee Lee Chan collaborates with scholars based in Malaysia, Egypt and United States. Lee Lee Chan's co-authors include Mohsen Saleh Elalfy, Vip Viprakasit, Maria Domenica Cappellini, Amal El‐Beshlawy, John B. Porter, Bernard Roubert, Dany Habr, Hishamshah Mohd Ibrahim, Chi Kong Li and Gabor Domokos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Transfusion.

In The Last Decade

Lee Lee Chan

21 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Lee Chan Malaysia	9	256	243	79	50	40	22	340
Güngör Nişli Türkiye	10	185 0.7×	124 0.5×	60 0.8×	20 0.4×	27 0.7×	23	287
Abdullah Al Jefri Saudi Arabia	9	291 1.1×	288 1.2×	77 1.0×	15 0.3×	31 0.8×	18	377
Angela Melpignano Italy	9	289 1.1×	253 1.0×	57 0.7×	19 0.4×	10 0.3×	24	358
Javier Garcés‐Eisele Mexico	12	285 1.1×	115 0.5×	27 0.3×	96 1.9×	22 0.6×	37	424
Alix O’Meara Switzerland	9	198 0.8×	133 0.5×	17 0.2×	21 0.4×	18 0.5×	19	319
Sidharth Totadri India	9	82 0.3×	62 0.3×	85 1.1×	74 1.5×	11 0.3×	41	254
Elena Cela Spain	10	224 0.9×	225 0.9×	98 1.2×	12 0.2×	4 0.1×	47	328
Ian Thornley Canada	11	182 0.7×	91 0.4×	59 0.7×	49 1.0×	6 0.1×	12	330
Simone Cristina Olenscki Gilli Brazil	13	315 1.2×	264 1.1×	56 0.7×	18 0.4×	5 0.1×	31	475
Mark T. Vander Lugt United States	6	250 1.0×	44 0.2×	37 0.5×	28 0.6×	10 0.3×	14	381

Countries citing papers authored by Lee Lee Chan

Since Specialization

Citations

This map shows the geographic impact of Lee Lee Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Lee Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Lee Chan more than expected).

Fields of papers citing papers by Lee Lee Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Lee Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Lee Chan. The network helps show where Lee Lee Chan may publish in the future.

Co-authorship network of co-authors of Lee Lee Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Lee Chan. A scholar is included among the top collaborators of Lee Lee Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Lee Chan. Lee Lee Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ariffin, Hany, Shirley Kow Yin Kham, Lee Lee Chan, et al.. (2023). Anthracycline-Free Protocol for Favorable-Risk Childhood ALL: A Noninferiority Comparison Between Malaysia-Singapore ALL 2003 and ALL 2010 Studies. Journal of Clinical Oncology. 41(20). 3642–3651. 5 indexed citations

Yeoh, Allen Eng Juh, Yi Lü, Zhenhua Li, et al.. (2018). Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study. Journal of Clinical Oncology. 36(26). 2726–2735. 46 indexed citations

Porter, John B., Mohsen Saleh Elalfy, Vip Viprakasit, et al.. (2015). Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment. European Journal Of Haematology. 96(1). 19–26. 26 indexed citations

Nathan, Anna Marie, et al.. (2014). Should All Children Admitted with Community Acquired Pneumonia have Blood Cultures Taken?. The Indian Journal of Pediatrics. 82(5). 439–444. 4 indexed citations

Porter, John B., Mohsen Saleh Elalfy, Alì Taher, et al.. (2014). Insights into Relationships Between Serum Ferritin and Liver Iron Concentration Trends during 12 Months of Iron Chelation Therapy with Deferasirox – a Post-Hoc Analysis from the Epic Study. Blood. 124(21). 52–52. 2 indexed citations

El‐Beshlawy, Amal, et al.. (2013). Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count. European Journal Of Haematology. 92(4). 337–340. 14 indexed citations

El‐Beshlawy, Amal, Mohsen Saleh Elalfy, Lee Lee Chan, et al.. (2012). Deferasirox Treatment for up to 3 Years in Iron-Overloaded Pediatric Patients Reduces Serum Ferritin with a Manageable Safety Profile. Blood. 120(21). 1028–1028. 1 indexed citations

Porter, John B., Mohsen Saleh Elalfy, Vip Viprakasit, et al.. (2012). Serum Ferritin, Labile Plasma Iron and Transferrin Saturation: Comparison Between Underlying Anemias with Transfusional Iron Overload Before and After Treatment with Deferasirox.. Blood. 120(21). 2126–2126. 2 indexed citations

Petz, Lawrence D., Tang‐Her Jaing, Joseph Rosenthal, et al.. (2011). Analysis of 120 pediatric patients with nonmalignant disorders transplanted using unrelated plasma‐depleted or ‐reduced cord blood. Transfusion. 52(6). 1311–1320. 5 indexed citations

10.

Viprakasit, Vip, Hishamshah Mohd Ibrahim, Sy Ha, et al.. (2011). Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox. International Journal of Hematology. 93(3). 319–328. 10 indexed citations

11.

Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2010). Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years. Blood. 116(21). 4276–4276. 6 indexed citations

12.

Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2009). Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia. Blood. 115(12). 2364–2371. 158 indexed citations

13.

Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2009). Efficacy and Safety of Deferasirox (Exjade®) in β-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study.. Blood. 114(22). 4062–4062. 4 indexed citations

14.

Elalfy, Mohsen Saleh, et al.. (2008). The Tolerability, Safety and Efficacy of a New Oral Solution of Deferiprone in Children with Transfusional Iron Overload. Blood. 112(11). 5373–5373. 2 indexed citations

15.

Tan, Jin Ai Mary Anne, et al.. (2006). Characterisation and confirmation of rare beta-thalassaemia mutations in the Malay, Chinese and Indian ethnic groups in Malaysia. Pathology. 38(5). 437–441. 16 indexed citations

16.

Jaing, Tang‐Her, Joseph Rosenthal, Auayporn Nademanee, et al.. (2006). Hematopoietic Stem Cell Transplantation (HSCT) Using Plasma Depleted Umbilical Cord Blood (UCB) That Were Not Red Cell Depleted.. Blood. 108(11). 5231–5231.

17.

Rosenthal, Joseph, Tang‐Her Jaing, Auayporn Nademanee, et al.. (2006). Hematopoietic Stem Cell Transplantation (HSCT) for Benign Indications Using Plasma Depleted Umbilical Cord Blood Units (UCB) That Were Not Depleted of Red Blood Cells.. Blood. 108(11). 3151–3151. 1 indexed citations

18.

George, Elizabeth, et al.. (2006). Molecular characterisation and frequency of Ggamma Xmn I polymorphism in Chinese and Malay beta-thalassaemia patients in Malaysia.. PubMed. 28(1). 17–21. 10 indexed citations

19.

Lee, Way Seah, et al.. (2005). Risks of seroconversion of hepatitis B, hepatitis C and human immunodeficiency viruses in children with multitransfused thalassaemia major. Journal of Paediatrics and Child Health. 41(5-6). 265–268. 11 indexed citations

20.

Chan, Lee Lee, Joann L. Ater, Ayten Cangır, et al.. (1996). Fractionated High-Dose Cyclophosphamide for Advanced Pediatric Solid Tumors. Journal of Pediatric Hematology/Oncology. 18(1). 63–67. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact